Results 61 to 70 of about 32,258 (154)
Prediction of Co-Occurrence of Lewy Body Disease with Alzheimer’s Disease
Identifying the coexistence of Lewy body (LB) pathology with Alzheimer’s disease (AD) in clinical practice is important in the era of anti-amyloid-β antibody therapy. However, few studies have predicted the presence of comorbid LB pathology with AD using
Kenichi Hashiguchi +6 more
doaj +1 more source
Background Dementia with Lewy bodies shares clinical and pathological features with both Parkinson’s disease and Alzheimer’s disease, but the local biological factors that render specific cortical regions vulnerable to atrophy remain poorly defined.
Aline Delva +15 more
doaj +1 more source
Frederic Lewy: how the two World Wars changed his life, work, and name
In 1912, Friedrich Lewy described the inclusion bodies present in Parkinson disease and in Lewy body dementia. Throughout his life, Lewy fought in two wars – on opposite sides.
Patrick Emanuell Mesquita Sousa-Santos +2 more
doaj +1 more source
Dementia Lewy Body (DLB) is a form of dementia characterized by abnormal accumulation of α-synuclein protein in the brain, forming lewy bodies that damage the function of neurons and nervous system.
Lubna Afina +4 more
doaj +1 more source
INTRODUCTION Lewy body pathology is commonly found in cardiac nervous tissue, including the cardiac conduction system. This study aimed to investigate the occurrence of sick sinus syndrome (SSS) and high‐degree atrioventricular block in dementia with ...
Isak Heyman +3 more
doaj +1 more source
A 100-year history of dementia with Lewy bodies
It takes more than one hundred years to understand dementia with Lewy bodies (DLB). Frederick Henry Lewy, a Germany doctor who studied the neuropathology of Parkinson's disease (PD) at Munich University, described eosinophilic intracytoplasmic inclusions
Wei YUE, Yong JI
doaj
Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body Dementia. [PDF]
Gibbons CH +31 more
europepmc +1 more source
The utility of a composite endpoint for tracking disease progression in Lewy body dementia. [PDF]
Matar E +8 more
europepmc +1 more source
Spatially resolved molecular signatures of Lewy body dementia. [PDF]
Jin Y +16 more
europepmc +1 more source

